IMPORTANT NOTICE: Please be aware, prior to sale, you are advised to have a short phone call consultation with our Pharmacist. Automatic purchase consents the Pharmacist to give you a quick call.
Viagra Connect is available without a Prescription but requires a brief consultation with the Pharmacist. It is available in a 4 pack or an 8 pack. Viagra Connect contains Sildenafil 50mg which works by relaxing the penis blood vessels, allowing blood to flow when you get aroused causing erections and potency. Viagra Connect will only help men become erect if you are aroused. Only for adult use, men 18 years plus.
How to be taken:
VIAGRA CONNECT is not to be taken if:
Please read instructions carefully provided.
Viagra Connect is a fast acting drug for erectile dysfunction which can last up to 4 hours and takes effect within 30 minutes after administration.
Sildenafil Citrate 50 mg Tablets: This tablet is specifically formulated to treat the symptoms of erectile disfunction and is highly effective in treating it, the most common sexual disorder affecting men over the age of 40 years. Provides a solution to erectile dysfunction in men who suffer from impotence due to conditions such as heart disease or diabetes, or who have problems with their physical or mental health.
Viagra Connect ensures fast and effective results that last as long as 36 hours and come without side effects. It works by relaxing the blood vessels in the penis, allowing blood to flow into the phallus when you get sexually excited and causing the desired stiffness.
windendkultz.com/cai-viagra-cai/forum-photos-photos-viagra-connect.htmPlease note: This product is only available with a prescription. Actual product may differ from the product shown on our website.
Share ShareCIPLA Pharma has established a Special Dispute Rule (SDR) to ensure that its Special Dispute Management Program is used by those facing a serious medical problem, particularly if they have been diagnosed with pulmonary hypertension (PAH). The SDR is designed to ensure that disputes do not appear to be related to the resolution of a serious medical problem. To succeed, CIPLA Pharma will be able to effectively manage a drug dispute over pricing, quality, route of administration, quality of the product and delivery method.
A SDR ensures that a drug is always under strict quality control. We advise that all drug products undergo a complete safety evaluation before they are allowed to be marketed.
Viagra Connect is a new erectile dysfunction treatment which does not require a prescription.
The first of its kind, Viagra Connect is a safe and discreet over-the-counter medication that can legally be bought online without a trip to your doctor.
We need to ensure that this medicine is suitable for the person it is intended for. Therefore, it should only be purchased by the person taking it.
A pharmacist may need to contact you by phone before providing the product. If they cannot reach you within 72 hours, your order may be delayed, or this item may be cancelled from your order.
Please ensure your contact details are correct before ordering this medicine.Suitable forViagra Connect is for men 18 years and older who have difficulty getting and/or keeping an erection hard enough for sex
Age RestrictionYou must be at least 18 years old to purchase this product.
Directions for use:Please read the enclosed leaflet carefully before use.
• take 1 tablet approximately one hour before sexual activity• swallow tablet whole with water• do not take more than 1 tablet a dayViagra Connect starts to work within 30-60 minutes. You may take it up to 4 hours before sexual activity.
Hazards and Cautions
Do NOT take if you:
Talk to your pharmacist or doctor before taking if you:
As with all medicines, please ensure you read the patient information leaflet before taking this item.
amberAlcohol or similar drugs may cause a dangerous drop in blood pressure.
ChampixIn product text and tracking, no additional charge is made by venturing into the world with your partner
30 ml packs
Viagra Connect contains Sildenafil 50mg which is the equivalent of Viagra®. It gets to the tingling area of the skin andDissolve in the mouth or onto a spoon and pour down with water. Viagra Connect may take up to 4 to 6 hours to die, so if you are able to with foreplay, sit or sit still and let others near you feel how you feel. Viagra Connect should only be taken once
Viagra Connect worksprevention of chest pain
Viagra Connect can cause temporary lightheaded or dizziness. As it will cause a rare side effect, it is recommended that you do not drive or operate heavy machinery after taking this drug. As with all medicines, please avoid exposure to heat, cold or cold causing side effects.You should not be given this medication if you are pregnant or breastfeeding. The following side effects have been reported:
Viagra Connect will only cause flushing in the eyesThis product contains the active substance Avanafil. It can cause a dangerous drop in blood pressure.The Food and Drug Administration (FDA) is warning consumers not to use Viagra, made by Pfizer Inc., on which the drug was developed, after it was approved by the U. S. Food and Drug Administration (FDA) in 1998.
The Food and Drug Administration (FDA) has issued a warning to the consumer of the drug's safety, although the warning did not appear on the label at the time of its approval. The warning is not listed on the drug's packaging, and the FDA has not approved the drug for sale.
The FDA has determined that Viagra is safe for use, although the drug is not as effective as some other drugs for treating erectile dysfunction.
The warning comes on the heels of a study by the University of Cincinnati that found Viagra was associated with a higher risk of death from cardiovascular disease. The FDA issued a similar warning in 1999, but the FDA didn't publish the findings until 2002, when it concluded that the drug wasn't safe for the patient and that the drug's safety was "not established".
However, Viagra isn't the only drug with safety concerns in the United States. Other popular drugs, such as Viagra, have been on the market since 1998. In 2010, the FDA issued a warning to consumers of the potential dangers of consuming alcohol while taking Viagra, although the agency did not address the issue of alcohol consumption.
The Food and Drug Administration has issued several warnings about the possible health risks associated with drinking alcohol while taking Viagra, but the FDA has not published a warning letter for this drug.
The Food and Drug Administration is also advising consumers not to use the drug to avoid consuming alcohol while taking Viagra, as it may cause harmful side effects. The FDA also has not released a warning letter for the drug, which is not included on the label, but the agency is conducting additional studies to determine its safety.
Background: Viagra (Sildenafil) is a drug that has shown promising results in the treatment of erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). However, a recent clinical trial did not demonstrate significant improvements in the prevalence or severity of ED with treatment.
Conclusions:Sildenafil-treated patients demonstrated a significant improvement in ED prevalence and ED severity compared with those who received tadalafil (the drug of choice for treatment of erectile dysfunction) as the sole treatment.
Keywords:Sildenafil, Viagra
Sildenafil (Viagra), a prescription drug for the treatment of erectile dysfunction in males, has been widely used in clinical practice as an effective treatment option for ED in various populations.
The objective of the present study was to assess the prevalence and severity of ED in patients with erectile dysfunction and pulmonary arterial hypertension (PAH) with tadalafil treatment. We also aimed to determine if the incidence of these conditions is different between treatment groups.
A retrospective study was conducted to investigate the prevalence of ED in patients with erectile dysfunction and pulmonary arterial hypertension. The patients were diagnosed with ED by the International Index of Erectile Function (IIEF) questionnaire at the time of the study. The prevalence was determined by the Global Initiative for Erectile Dysfunction (GID) classification according to the WHO (WHO) IIEF. Patients who took sildenafil were excluded if they had an International Index of Erectile Function (IIEF) score of 4 or less in the IIEF questionnaire.
The objective of this study was to determine if the prevalence of ED was different between treatment groups. The prevalence was determined by the mean age ± SD of the patients who received sildenafil or tadalafil. This study was performed to analyze the incidence of ED and pulmonary arterial hypertension.
Patients were randomly assigned to either tadalafil treatment or sildenafil treatment.
The patients were assessed at baseline, 4, 8, and 12 months after starting treatment, by the International Index of Erectile Function (IIEF) questionnaire. The IIEF questionnaire has been used widely in the treatment of erectile dysfunction and pulmonary arterial hypertension in various clinical trials.
The study design was prospective, and the follow-up period was 4.5 ± 2.5 months (mean ± SD).
The primary outcome was the occurrence of ED and pulmonary arterial hypertension in patients who were treated with tadalafil.
The secondary outcomes included the prevalence of ED in patients with erectile dysfunction and pulmonary arterial hypertension. The prevalence of ED in patients with ED was determined by the International Index of Erectile Function (IIEF) questionnaire.
The primary outcome was the prevalence of ED in patients who were treated with tadalafil. This outcome was assessed by the Global Initiative for Erectile Dysfunction (GID) classification according to the WHO (WHO) IIEF.